MergerApr 24, 2026, 04:12 PM
Senti Biosciences Completes Holding Company Reorganization
AI Summary
Senti Biosciences, Inc. completed its previously announced holding company reorganization on April 24, 2026. This involved a merger where Senti Biosciences became a wholly-owned subsidiary of Senti Holdings, which is a wholly-owned subsidiary of Senti Biosciences Holdings, Inc. As a result, Senti Biosciences Holdings, Inc. is now the successor issuer to Senti Biosciences, Inc.
Key Highlights
- Senti Biosciences completed its holding company reorganization on April 24, 2026.
- Senti Biosciences merged into Merger Sub, becoming a wholly-owned subsidiary of Senti Holdings.
- Senti Biosciences Holdings, Inc. became the successor issuer to Senti Biosciences, Inc.
Price Impact
More from SNTI